Scarica l'app Stockscreener
7.52
1.44%
-0.11
Dopo l'orario di chiusura:
7.91
0.39
+5.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.63
Aprire:
$7.68
Volume 24 ore:
86,018
Relative Volume:
0.62
Capitalizzazione di mercato:
$256.83M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-12.33
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
-2.34%
1M Prestazione:
-10.69%
6M Prestazione:
-14.16%
1 anno Prestazione:
+22.68%
Intervallo 1D:
$7.48
$8.00
Intervallo di 1 settimana:
$7.295
$8.34
Portata 52W:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Nome
Fennec Pharmaceuticals Inc
Settore
Industria
Telefono
(919) 636-4530
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.52 | 256.83M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Iniziato | B. Riley Securities | Buy |
| 2026-01-09 | Iniziato | Piper Sandler | Overweight |
| 2022-11-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Iniziato | CapitalOne | Overweight |
| 2022-08-08 | Ripresa | Craig Hallum | Buy |
| 2020-06-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Iniziato | Goldman | Buy |
Mostra tutto
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Adherex Technologies (NASDAQ:FENC) Cut to Buy at Wall Street Zen - Defense World
Liquidity Mapping Around (FENC) Price Events - Stock Traders Daily
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Hits Day Low of CAD 10.35 Amid Price Pressure - Markets Mojo
Adolescent cancer patients face unique survivorship hurdles, Fennec Pharmaceuticals asserts - Traders Union
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will Fennec Pharmaceuticals Inc. stock maintain growth story2025 Sector Review & Fast Exit and Entry Strategy Plans - Naître et grandir
Can Fennec Pharmaceuticals Inc sustain earnings growth2025 Bull vs Bear & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Fennec Pharmaceuticals (TSX:FRX) Moves Higher on Renewed Trading Focus - Kalkine Media
Aug Chart Watch: Does Fennec Pharmaceuticals Inc outperform in volatile marketsJuly 2025 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving AverageWhat's Next? - MarketBeat
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline - Finviz
Fennec, Tampa General launch real-world PEDMARK oncology study - TipRanks
Fennec (FENC) backs PEDMARK real-world study at Tampa General - Stock Titan
Dow Update: Why is Fennec Pharmaceuticals Inc stock going downJuly 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals Inc. - Baystreet.ca
Fennec Pharmaceuticals Collaborates With TGH Cancer Institute for Pedmark Study - marketscreener.com
Fennec Pharmaceuticals Inc. and Tampa General Hospital Cancer Institute Initiate Clinical Research Collaboration - marketscreener.com
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewswire
Fennec (NASDAQ: FENC) CFO acquires 1,191 common shares via award vesting - Stock Titan
Fennec Pharmaceuticals (FENC) director trades options and common shares - Stock Titan
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
FENC (NASDAQ: FENC) insider files to sell 10,079 shares via option exercise - Stock Titan
Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Finviz
FENC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Adherex Technologies (FENC) to Release Quarterly Earnings on Monday - MarketBeat
FENC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
FENC Should I Buy - Intellectia AI
FENC SEC FilingsFennec Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Public market insider buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail
(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily
Quarterly Trades: Is ZVIA stock forming a cup and handleTrade Volume Report & Technical Pattern Alert System - baoquankhu1.vn
Portfolio Update: Can Fennec Pharmaceuticals Inc stock outperform in a bear marketEarnings Risk Summary & Fast Moving Stock Watchlists - baoquankhu1.vn
Chipmakers Recap: Why is Fennec Pharmaceuticals Inc stock going down2025 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
(FRX) Advanced Equity Analysis (FRX:CA) - Stock Traders Daily
Will Fennec Pharmaceuticals Inc. stock benefit from upcoming earnings reportsWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Fennec Pharmaceuticals presents real-world data showing PEDMARK feasible, well tolerated in adults with head & neck cancer - TradingView
New PEDMARK real-world data in adult head & neck cancer from Fennec (NASDAQ: FENC) - Stock Titan
Is Fennec Pharmaceuticals Inc. still a buy after recent gainsRecession Risk & Advanced Swing Trade Entry Plans - mfd.ru
Fennec Showcases Real-World Data Backing PEDMARK Use in Adult Head and Neck Cancer - TipRanks
Fennec Pharmaceuticals Inc. Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK®? in Treating Adults with Head & Neck Cancers - marketscreener.com
Cancer drug timing tweak shows promise for preserving hearing - Stock Titan
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers - The Manila Times
Fennec Pharmaceuticals (FENC) CEO granted 13,710 shares as PSUs vest - Stock Titan
Fennec (NASDAQ: FENC) CFO adds shares via option exercise and PSU vesting - Stock Titan
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
When the Price of (FRX) Talks, People Listen (FRX:CA) - Stock Traders Daily
Will Fennec Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Smart Swing Trading Techniques - mfd.ru
Insider Selling: Fennec Pharmaceuticals (TSE:FRX) Director Sells 10,349 Shares of Stock - MarketBeat
Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):